2X MATCH: 2X MATCH: Today, your gift is DOUBLED for 2X the impact on lifesaving research.
Clear Search

From Research to Results

Our Impact

We invest in research that’s changing how we think about cancer. That means more answers, faster breakthroughs, and personalized treatment for every patient. With more than a billion dollars raised to fuel our mission, that’s progress. This year, BCRF is the largest private funder of breast cancer research—and the largest private funder of metastatic research—in the U.S.

The Ground We've Gained

Research is revolutionizing our understanding of breast cancer and bringing us closer to a cure. Discover how far science has come since BCRF’s founding in 1993—and how our investigators have been involved in every major breakthrough.



We Fund the Best Researchers in the World

Meet the Game Changers

Today, we support more than 250 scientists making a real difference and accelerating progress. Get to know them and learn about their projects.


Our Areas of Focus

Breast cancer is a complex disease with no simple solution, which is why our researchers are tackling it from every angle. Learn about our areas of focus and why each is critical to knowing how to fight cancer from the start, slow its progress and one day stop it from occurring altogether.

Heredity & Ethnicity

Most people who develop breast cancer have no family history of the disease, but we know that’s not always the case. A person’s family history, inheritance, race and ethnicity are all important risk factors that have long been part of our research agenda. Our scientists have been behind major breakthroughs in this area, including discovering the role BRCA1 and BRCA2 play in breast cancer and uncovering the genetic link to more aggressive forms of the disease in women of African descent. The more progress our researchers make, the better doctors are able to predict who is at risk and what can be done to prevent cancer’s onset.


Heredity & Ethnicity Researchers

Yehoda M. Martei, MD, MSCE

Titles and Affiliations Assistant Professor of Medicine American Association of Cancer Research Research area...

BCRF Investigator Since


Alvaro Monteiro, PhD

Titles and Affiliations Senior Member, Population Sciences Division H. Lee Moffitt Cancer Center Professor,...

BCRF Investigator Since


Christine B. Ambrosone, PhD

Dr. Ambrosone is a Distinguished Professor of Oncology, Chair of the Department of Cancer...

BCRF Investigator Since


Marjory Charlot, MD, MPH, MSc

Titles and Affiliations Assistant Professor of Medicine, Division of Oncology, School of Medicine Assistant...

BCRF Investigator Since


Fergus J. Couch, PhD

Titles and Affiliations Professor of Laboratory Medicine And Pathology Zbigniew and Anna M. Scheller...

BCRF Investigator Since


Melissa B. Davis, PhD

Titles and Affiliations Scientific Director, International Center for the Study of Breast Cancer Subtypes...

BCRF Investigator Since


Susan M. Domchek, MD

Susan M. Domchek, MD is the Basser Professor in Oncology at the Perelman School...

BCRF Investigator Since


Charis Eng, MD, PhD, FACP

Titles and Affiliations Chairwoman, Genomic Medicine Institute, Cleveland Clinic American Cancer Society Clinical Research...

BCRF Investigator Since


Temidayo Fadelu, MD, MPH

Titles and Affiliations Physician, Medical Oncology, Dana-Farber Cancer Institute Instructor, Medicine, Harvard Medical School...

BCRF Investigator Since


James M. Ford, MD, FASCO

Titles and Affiliations Professor of Medicine, Genetics, and Pediatrics Director, Stanford Cancer Genetics Clinic...

BCRF Investigator Since


Collaborative Initiatives

Impactful breast cancer research isn’t siloed. BCRF helps power several large, multi-year research efforts across institutions and industries.